Trial Profile
A prospective, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hypertensive women with sexual interest and arousal disorder
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 May 2019
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors Laboratorios Litaphar
- 24 May 2019 Status changed from recruiting to discontinued.
- 22 Jun 2016 New trial record